Coagulation Factor Concentrates
Coagulation Factor Concentrates is a therapeutic biological product comprising purified or recombinant human clotting factors that, when administered intravenously, selectively correct specific coagulation factor deficiencies to restore hemostatic balance in patients with congenital or acquired bleeding disorders.
1.2K
Publications
56.5K
Citations
4.2K
Authors
1.2K
Institutions
Publications per year
2017–2026
119
Variants
Cfcs
Parents
1.2K
WFH Guidelines for the Management of Hemophilia, 3rd edition
Alok Srivastava, Elena Santagostino, Alison Dougall et al. · Haemophilia · 2020 · 1.9K citations · Full text
1–5 of 1.2K
4.2K
19
h-index
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Italy
19 publications · 3.5K citations
19
h-index
15
h-index
14
h-index
National Institute for Biological Standards and Control, United Kingdom
15 publications · 474 citations
14
h-index
1–5 of 4.2K
1.2K
University College London
London, United Kingdom
27 h-index
150 publications
11.2K citations

University of Milan
Milan, Italy
26 h-index
119 publications
5.4K citations

Lund University
Lund, Sweden
25 h-index
75 publications
5.1K citations

The Royal Free Hospital
London, United Kingdom
22 h-index
107 publications
7.9K citations
National Institute for Biological Standards and Control
Potters Bar, United Kingdom
21 h-index
77 publications
2.5K citations

University of Toronto
Toronto, Canada
19 h-index
59 publications
7K citations

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy
19 h-index
83 publications
5.8K citations

Churchill Hospital
Oxford, United Kingdom
18 h-index
88 publications
2.9K citations
1–8 of 1.2K
204 publications · 9.1K citations
46
h-index
62 publications · 4.6K citations
40
h-index
104 publications · 5.1K citations
38
h-index
BJH · 65 publications · 3.3K citations
31
h-index
50 publications · 1.9K citations
28
h-index
1–5